Axis 2
Studiedness
- Evidence amount
- 0.75
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 5
- Records after title/year deduplication
- 5
entity · release 2026-09-20
Bifidobacterium animalis B94
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Forms
- Capsule: 4 · counted across the 4 of 4 published products whose label states a form
- Brands carrying it
- innosupps (1) · ombre (1) · viva-naturals (2)
- Published product pages
- 4
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| Ombre Metabolic Booster | not printed | not printed | not observed | Capsule | 61.75 |
| INNOSUPPS UT Balance | not printed | not printed | not observed | Capsule | 57.08 |
| Viva Naturals Advanced Probiotics 50 Billion CFU | not printed | not printed | not observed | Capsule | 56.27 |
| Viva Naturals Probiotics for Women | not printed | not printed | not observed | Capsule | 54.44 |
Containing labels4
Evidence amount0.75
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
5 records (retracted records excluded; 0 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
- 2020 · Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.
- 2019 · Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study.
- 2017 · The Effects of Synbiotic "Bifidobacterium lactis B94 plus Inulin" Addition on Standard Triple Therapy of Helicobacter pylori Eradication in Children.
- 2017 · Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
- 2016 · Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial.
ClinicalTrials.gov
2 interventional studies. ClinicalTrials.gov query
This species has 56 tracked designations; this one appears on 4 labels (median 4.5).
Other printed names
- Bifidobacterium animalis B-94
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 4 of 4 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| Ombre | Metabolic Booster | 317009 | 61.75 | true | not printed for this organism | not stated | 1 |
| INNOSUPPS | UT Balance | 303195 | 57.08 | true | not printed for this organism | at manufacture | 1 |
| Viva Naturals | Advanced Probiotics 50 Billion CFU | 247987 | 56.27 | true | not printed for this organism | not stated | 1 |
| Viva Naturals | Probiotics for Women | 309779 | 54.44 | true | not printed for this organism | not stated | 1 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Bifidobacterium animalis B94. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/bifidobacterium-animalis-b94/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Bifidobacterium animalis B94 appears on 4 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 3 brands; tied with 43 designations by distinct label count.
4 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 4 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Bifidobacterium animalis B94 (0.0%); 0 light records have quantities unavailable.
0 / 4 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f7324375 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 5 records (retracted records excluded; 0 retracted records match the query separately).
5 / 5 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324372 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
2 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 4 SKUs containing Bifidobacterium animalis B94 have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.
0 / 4 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437